Healthcare data exchange still runs, in large part, on a 35-year-old messaging format. HL7v2 powers the vast majority of interfaces between EHRs, lab systems, and billing platforms today, even as FHIR (Fast Healthcare Interoperability Resources) has become the default standard for new integrations, patient apps, and regulatory mandates. For healthcare IT leaders planning system upgrades, vendor selection, or interoperability roadmaps, the FHIR vs HL7 decision isn’t academic. It shapes budgets, timelines, and how easily your organization can meet upcoming compliance requirements.
This guide breaks down the practical differences, where each standard fits, and how to plan a migration path that doesn’t disrupt existing operations.
What HL7v2 Is and Why It’s Still Everywhere
See Contents
HL7 Version 2 (HL7v2) emerged in the late 1980s as a pipe-delimited messaging standard for exchanging clinical data between systems, admissions, lab results, orders, and billing events. Messages like ADT (Admit-Discharge-Transfer) and ORU (Observation Result) became the backbone of hospital IT.
HL7v2’s strengths are also its limitations:
- Loose structure. The standard allows significant local customization, which means two hospitals’ “HL7v2 feeds” often aren’t interchangeable without custom mapping.
- Point-to-point design. It was built for direct system-to-system messaging, not for web-scale or app-based access.
- No native REST/JSON support. Integration typically requires interface engines (Mirth, Rhapsody, Cloverleaf) to translate and route messages.
Despite this, HL7v2 remains deeply embedded in hospital infrastructure. Replacing it outright is rarely realistic in the near term; most large health systems still depend on it for core ADT and lab workflows.
What FHIR Brings to the Table
FHIR, developed by HL7 International and first published in 2014, was designed to address HL7v2’s shortcomings using modern web technology. It structures healthcare data into discrete “resources” (Patient, Observation, MedicationRequest, Encounter) accessible via RESTful APIs, using JSON or XML.
Key advantages:
- API-first architecture. FHIR aligns with how modern software is built, making it far easier for app developers, patient portals, and third-party platforms to consume clinical data.
- Granular, resource-based data model. Instead of monolithic messages, FHIR exposes individual, well-defined data objects.
- Stronger interoperability out of the box. Implementation Guides (like US Core) reduce the variability that plagues HL7v2 deployments.
- Regulatory alignment. In the US, the ONC’s Cures Act Final Rule and CMS interoperability rules require FHIR-based APIs for patient data access — a mandate HL7v2 cannot fulfill.
FHIR vs HL7: A Side-by-Side Comparison
| Dimension | HL7v2 | FHIR |
|---|---|---|
| Format | Pipe-delimited text | JSON / XML over REST |
| Data model | Message-based | Resource-based |
| Integration style | Point-to-point, interface engines | API-driven, web-native |
| Standardization | Highly variable by implementation | More consistent via Implementation Guides |
| Developer accessibility | Requires specialized HL7 tooling knowledge | Familiar to general web/app developers |
| Regulatory status | Legacy, still widely deployed | Mandated for patient-facing data access (US) |
| Best suited for | Established internal hospital workflows (ADT, orders, results) | Patient apps, third-party integrations, population health, analytics |
The FHIR vs HL7 comparison isn’t really “old vs. new” in a way that makes one obsolete. It’s closer to “internal plumbing vs. external connectivity”, and most health systems now need both.
Why Most Organizations Run Both, Not Either/Or
A common misconception is that adopting FHIR means retiring HL7v2. In practice, most healthcare IT environments run a hybrid model for years:
- Core clinical workflows (lab orders, ADT feeds, pharmacy interfaces) often stay on HL7v2 because replacing them carries operational risk with limited near-term benefit.
- New patient-facing capabilities, apps, portals, third-party data sharing, care coordination platforms are built on FHIR to meet both regulatory requirements and developer expectations.
- Interface engines increasingly support HL7v2-to-FHIR translation, letting legacy systems participate in FHIR-based ecosystems without a full rip-and-replace.
This hybrid approach is the practical reality for most hospitals and health systems, not a compromise to be “fixed” later.
Decision Framework for IT Leaders
When evaluating where FHIR vs HL7 fits into your roadmap, a few questions help clarify priorities:
1. Is this a regulatory requirement?
If the use case involves patient access to their own data, payer data exchange, or public health reporting under current mandates, FHIR is generally the required path.
2. Is this an internal, high-volume clinical workflow?
For established ADT, order, and result feeds where the interface already works reliably, a forced migration to FHIR may introduce risk without proportional benefit — at least in the short term.
3. Who will consume the data?
If external developers, app builders, or third-party platforms need access, FHIR’s REST/JSON model dramatically lowers the integration burden compared to HL7v2.
4. What’s your interface engine’s FHIR maturity?
Many organizations bridge the two standards through their existing integration engine rather than building FHIR support from scratch. Assessing this capability early avoids redundant tooling investment.
5. What’s the total cost of parallel maintenance?
Running both standards means maintaining two sets of interface logic, monitoring, and staff expertise. Budget and staffing plans should account for this dual-track reality, not assume a clean cutover.
Practical Next Steps
- Audit existing interfaces to identify which are strong candidates for FHIR-based replacement versus those that should remain on HL7v2 for now.
- Prioritize FHIR adoption where regulatory deadlines apply — patient access APIs, provider directory exposure, and payer-to-payer data exchange are common starting points.
- Invest in interface engine capabilities that support bidirectional HL7v2-FHIR translation, reducing the need for parallel, disconnected integration stacks.
- Build internal FHIR expertise gradually, since most legacy HL7 interface teams will need upskilling rather than replacement.
Conclusion
The FHIR vs HL7 debate isn’t about choosing a winner; it’s about sequencing. HL7v2 continues to power core hospital workflows like ADT feeds, lab orders, and pharmacy interfaces, and replacing these stable systems without clear justification rarely makes sense operationally or financially. FHIR, meanwhile, has become non-negotiable for patient-facing applications and regulatory compliance, making it a parallel priority rather than a distant one.
The healthcare organizations that handle this best don’t force an all-or-nothing migration. They audit their existing interfaces, use interface engines to bridge HL7v2 and FHIR where needed, and build FHIR expertise incrementally, all while keeping proven HL7v2 workflows intact where they still deliver value.
Ultimately, success in the FHIR vs HL7 landscape comes down to matching the right standard to the right use case, on a timeline that protects both compliance and operational stability.
Ready to modernize your healthcare interoperability strategy? Connect with Emorphis Health integration experts to assess your current HL7v2 and FHIR readiness and build a migration roadmap tailored to your systems.
